• Kazuki M Matsuda, Divya Sharma, Ariel R Schonfeld, and Shawn G Kwatra.
• Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
• J. Am. Acad. Dermatol. 2016 Sep 1; 75 (3): 619-625.e6.

AbstractChronic pruritus is a distressing symptom that is often refractory to treatment. Patients frequently fail topical therapies and oral over-the-counter antihistamines, prompting the clinician to consider alternative therapies such as neuroactive agents. Herein, the use of gabapentin and pregabalin, 2 medications well known for treating neuropathic pain and epilepsy that are occasionally used for relieving chronic pruritus is explored. The findings from original sources published to date to evaluate the use of gabapentin and pregabalin as antipruritic agents are explored. They are found to be promising alternative treatments for the relief of several forms of chronic pruritus, particularly uremic pruritus and neuropathic or neurogenic itch, in patients who fail conservative therapies. Copyright © 2016 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

29 keywords...

hide…